Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma.
about
Activation of DNA Damage Response Induced by the Kaposi's Sarcoma-Associated Herpes VirusThe inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approachLipoxins: nature's way to resolve inflammationKSHV: pathways to tumorigenesis and persistent infectionThe crystal structure of the DNA-binding domain of vIRF-1 from the oncogenic KSHV reveals a conserved fold for DNA binding and reinforces its role as a transcription factorKS-Detect - Validation of Solar Thermal PCR for the Diagnosis of Kaposi's Sarcoma Using Pseudo-Biopsy SamplesThe changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle-aged men and differs from time trends in systemic diffuse large B-cell non-Hodgkin's lymphoma.Epidemiology and genetic variability of HHV-8/KSHV in Pygmy and Bantu populations in Cameroon.Non-detection of human herpesvirus 8 (HHV-8) DNA in HHV-8-seropositive blood donors from three Brazilian regions.KSHV PAN RNA associates with demethylases UTX and JMJD3 to activate lytic replication through a physical interaction with the virus genome.The horizon for treating cutaneous vascular lesionsAltering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.Changes in the pattern of Kaposi's sarcoma at Ocean Road Cancer Institute in Tanzania (2006-2011).A multiplex panel of plasma markers of immunity and inflammation in classical kaposi sarcoma.Treatment outcomes of AIDS-associated Kaposi's sarcoma under a routine antiretroviral therapy program in Lilongwe, Malawi: bleomycin/vincristine compared to vincristine monotherapy.Biodistribution and pharmacokinetics of 188Re-liposomes and their comparative therapeutic efficacy with 5-fluorouracil in C26 colonic peritoneal carcinomatosis mice.Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era.CpG methylation as a tool to characterize cell-free Kaposi sarcoma herpesvirus DNA.Tiled microarray identification of novel viral transcript structures and distinct transcriptional profiles during two modes of productive murine gammaherpesvirus 68 infection.A major locus on chromosome 3p22 conferring predisposition to human herpesvirus 8 infectionA case report of immunosuppression-related Kaposi's sarcoma after autologous stem cell transplantation.Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy.Changes in Clinical Context for Kaposi's Sarcoma and Non-Hodgkin Lymphoma Among People With HIV Infection in the United States.Oral HIV-Associated Kaposi Sarcoma: A Clinical Study from the Ga-Rankuwa Area, South AfricaRisk of Classic Kaposi Sarcoma With Combinations of Killer Immunoglobulin-Like Receptor and Human Leukocyte Antigen Loci: A Population-Based Case-control StudyCancer risk among the HIV-infected elderly in the United States.A Unique Case of Classic Kaposi's sarcoma restricted to the toes.The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency.Efficient infection of a human B cell line with cell-free Kaposi's sarcoma-associated herpesvirus.p120-catenin regulates VE-cadherin endocytosis and degradation induced by the Kaposi sarcoma-associated ubiquitin ligase K5.Molecular Epidemiology of Kaposi's Sarcoma-Associated Herpes Virus, and Risk Factors in HIV-infected Patients in Tehran, 2014.Transcription factor PROX1: its role in development and cancer.KSHV targeted therapy: an update on inhibitors of viral lytic replication.Recent advances in the study of Kaposi's sarcoma-associated herpesvirus replication and pathogenesis.Claudin-2 downregulation by KSHV infection is involved in the regulation of endothelial barrier function.Metabolic reprogramming: a hallmark of viral oncogenesis.High seroprevalence of antibodies against Kaposi's sarcoma-associated herpesvirus (KSHV) among HIV-1-infected children and adolescents in a non-endemic population.Kaposi's sarcoma presenting as violaceous macules on the chest of a kidney transplanted patient.Detection of Chlamydophila pneumoniae and human herpesvirus 8 in primary cutaneous anaplastic large-cell lymphoma: a case report.Chemokines encoded by herpesviruses.
P2860
Q26743368-8BD7A9CC-0989-4555-9592-38AF1AEE6CDCQ26765937-9DBD8111-98C9-44DC-9AFF-0A8B621E21B7Q26784376-6969E180-1A4B-4954-BC06-E7C7BB0B982DQ27026000-E80F8914-3731-437D-B198-DDCEFB187470Q27676606-5BA0084C-A74B-401A-9AF1-EB61B77289BEQ33446895-6D69F67D-4DAF-4BEF-BDA4-C2698C6B18BBQ33608166-4FEC1A93-CA68-4590-BCB3-7526E8DE19B3Q33618403-646E16B2-3433-4C38-BFCA-AA800BFF387AQ33999780-93823659-796D-4930-8939-4FD10E97DFD3Q34270407-03D7DD05-D8D1-4140-B2BB-01A4C8707CD3Q34277708-E2998C77-A143-4991-8EEF-D7284B8261AFQ34541350-BE262134-C22C-4A53-849B-53B7D799D7A2Q35032805-A4CE9B84-1517-4F65-9223-E79C2A3C3FE2Q35102683-B2E76E46-EA5E-4A6A-AAC4-BF394C3025D7Q35121796-2B21C7B7-6A43-4999-A2BA-58048ACCFEAFQ35556903-D90BD8E9-72FA-448C-A13C-AC3EB5D49351Q35557475-802E3E57-4B0D-41BA-88E8-0FAFFB88F118Q35808625-C6887432-028C-4469-BDE6-A38E702F5849Q35867993-E3C0CD17-2948-42F0-ABCD-48B782AD0B3AQ35969066-51336A44-237E-4FD5-8184-25A9562B653FQ35969629-1A182477-526C-49A1-ACBD-64D14604CA2FQ36058281-14E55810-C342-47E8-B578-9E8D170E43F5Q36099911-5A5E7D34-67AB-4ACF-AC23-E9E31C77D866Q36248446-2D56CCD7-9583-481A-9C38-84DD71DE2C07Q36481429-F7D87863-6357-4879-BBC3-EEFE9FFDF341Q36957697-6C95B657-90AD-45F5-AF4C-8303A9FF1C8AQ37230610-29691635-D18E-4706-9560-0071608D8545Q37380228-40088580-BB23-4DD1-AF4A-F09CD7A60EF2Q37547223-C40E9303-5C26-4768-92B6-AF3D7AABE257Q37573393-5478B443-2937-4698-B8D0-9EABFADAB072Q37625556-42395E1A-20AF-4BAC-96E3-A4282D3E1691Q38021685-40755060-D58F-4EBA-AEF4-3B126D256042Q38271135-64E3F885-456A-4D30-BF91-69F2D99B9FC4Q38449592-984B8BC1-D9C4-4D58-B4F6-33F27D59688DQ38475163-1397BA95-4688-43BD-9D91-47E1914D0D1DQ38674284-8D3A0DCF-261D-440B-BC7E-227E460F9CF2Q38860797-F50B5960-4D19-4F86-8C69-8542D2BD6BE4Q38915196-C0313946-9D9A-4F08-AF4B-00B7BF9B6608Q39338446-AA690224-655E-4B87-AD78-FA3FF4A9D92DQ40067378-E87511EA-9808-49FA-A220-9784E7B52DE9
P2860
Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Update on KSHV epidemiology, K ...... d treatment of Kaposi Sarcoma.
@ast
Update on KSHV epidemiology, K ...... d treatment of Kaposi Sarcoma.
@en
Update on KSHV epidemiology, K ...... d treatment of Kaposi Sarcoma.
@nl
type
label
Update on KSHV epidemiology, K ...... d treatment of Kaposi Sarcoma.
@ast
Update on KSHV epidemiology, K ...... d treatment of Kaposi Sarcoma.
@en
Update on KSHV epidemiology, K ...... d treatment of Kaposi Sarcoma.
@nl
prefLabel
Update on KSHV epidemiology, K ...... d treatment of Kaposi Sarcoma.
@ast
Update on KSHV epidemiology, K ...... d treatment of Kaposi Sarcoma.
@en
Update on KSHV epidemiology, K ...... d treatment of Kaposi Sarcoma.
@nl
P2860
P1433
P1476
Update on KSHV epidemiology, K ...... d treatment of Kaposi Sarcoma.
@en
P2093
Denise Whitby
Thomas S Uldrick
P2860
P304
P356
10.1016/J.CANLET.2011.02.006
P407
P577
2011-03-04T00:00:00Z